Form 4 Oracle, LLC: Boston, MA -- Form4Oracle: Insider Trading Report: DOR BioPharma, Inc. (DORB.OB)

- Sigma Tau Finanziaria Spa, 10% Owner: reported buying $1,000.00K

- Cavazza Paolo, 10% Owner: reported buying $1,000.00K

- Cavazza Claudio, 10% Owner: reported buying $1,000.00K

Over the last four weeks insiders at DOR BioPharma, Inc. (DORB.OB) have bought more than $3.00M:

- Sigma Tau Finanziaria Spa, 10% Owner: bought $1,000.00K increasing total holdings by 9%

- Cavazza Paolo, 10% Owner: bought $1,000.00K increasing total holdings by 9%

- Cavazza Claudio, 10% Owner: bought $1,000.00K increasing total holdings by 9%

For a current, real-time summary of DORB.OB insider activity, visit http://www.form4oracle.com/company/dor-biopharma-inc-dorb.ob?id=5011

About Form4Oracle

Form4Oracle, LLC specializes in distributing insider trading information published by the SEC, making it accessible and actionable for all types of investors. To learn more about how tracking insider trading activity can improve your investment returns, visit http://www.form4oracle.com.

About DOR BioPharma, Inc.

DOR BioPharma, Inc., a biopharmaceutical company, engages in the research and development of oral therapeutic products intended for areas of unmet medical needs and biodefense vaccines in the United States and internationally. The company operates through two segments, BioTherapeutics and BioDefense. The BioTherapeutics segment develops orBec, an orally administered corticosteroid, which exerts a potent and local anti-inflammatory effect in the mucosal tissue of the gastrointestinal tract; Oraprine, an oral suspension of azathioprine; and LPE and PLP systems for delivery of water-insoluble drugs. The BioDefense segment offers RiVax, ricin toxin vaccine, a heat stable toxin that is isolated and purified from the bean of the castor plant; and BT-VACC, the Botulinum toxin, a poisonous natural substance, which causes acute, symmetric, and descending flaccid paralysis due to its action on peripheral cholinergic nerves. DOR BioPharma, Inc. was founded in 1987 and is headquartered in Ewing, New Jersey.

--------------------------------------------

The companies referenced in this report have not approved the statements made in this report. This report contains statements that imply risks and uncertainties. This material is for informational reporting purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Form4Oracle is not a licensed broker, broker dealer, market maker, investment banker, investment adviser, analyst or underwriter and is not compensated in this regard.

Please consult your broker to understand investing benefits and risks and prior to purchasing any securities mentioned herein.

CONTACT: Kimberly Sutton, Form4Oracle
Tel: +1 312 315 5077
e-mail: kimberly@form4oracle.com
WWW: http://www.form4oracle.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on (DORB) DORB. (DORB) has Short Term PowerRatings at TradingMarkets. Details on (DORB) Short Term PowerRatings is available at This Link.